Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nuclear retinoic acid receptor binding	PRAMEF14 MED1 PRAMEF1 PRAMEF2	1.70e-05	55	56	4	GO:0042974
GeneOntologyMolecularFunction	transcription factor binding	ZBTB49 SP100 NFATC1 NFATC3 PRAMEF14 CAMTA2 MED1 PRAMEF1 PRAMEF2	2.27e-04	753	56	9	GO:0008134
GeneOntologyMolecularFunction	DNA-binding transcription repressor activity, RNA polymerase II-specific	ZNF512B ZBTB49 HOXD9 NFATC1 NFATC3 ZNF589	2.67e-04	320	56	6	GO:0001227
GeneOntologyMolecularFunction	DNA-binding transcription repressor activity	ZNF512B ZBTB49 HOXD9 NFATC1 NFATC3 ZNF589	2.95e-04	326	56	6	GO:0001217
GeneOntologyMolecularFunction	transcription coactivator binding	ZBTB49 NFATC1 MED1	4.68e-04	54	56	3	GO:0001223
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	SP100 NFATC1 PRAMEF14 MED1 PRAMEF1 PRAMEF2	1.08e-03	417	56	6	GO:0061629
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	ZBTB49 SP100 NFATC1 PRAMEF14 MED1 PRAMEF1 PRAMEF2	1.16e-03	582	56	7	GO:0140297
GeneOntologyMolecularFunction	ubiquitin-like ligase-substrate adaptor activity	PRAMEF14 PRAMEF1 PRAMEF2	1.58e-03	82	56	3	GO:1990756
GeneOntologyMolecularFunction	nuclear receptor binding	PRAMEF14 MED1 PRAMEF1 PRAMEF2	1.87e-03	187	56	4	GO:0016922
GeneOntologyBiologicalProcess	anatomical structure formation involved in morphogenesis	RBM15 SP100 PIK3R6 NFATC1 NFATC3 ADAMTS9 EPHA2 PRAMEF14 CACNA1H MED1 EPB41L3 PRAMEF1 PRAMEF2 PALB2 NOTCH3 B4GALT1	1.25e-06	1483	56	16	GO:0048646
GeneOntologyBiologicalProcess	branching morphogenesis of an epithelial tube	RBM15 NFATC1 NFATC3 EPHA2 LAMA1 MED1	1.58e-05	198	56	6	GO:0048754
GeneOntologyBiologicalProcess	tube morphogenesis	RBM15 SP100 PIK3R6 NFATC1 NFATC3 ADAMTS9 GLI1 EPHA2 LAMA1 MED1 NOTCH3 B4GALT1	3.92e-05	1125	56	12	GO:0035239
GeneOntologyBiologicalProcess	morphogenesis of a branching epithelium	RBM15 NFATC1 NFATC3 EPHA2 LAMA1 MED1	4.24e-05	236	56	6	GO:0061138
GeneOntologyBiologicalProcess	striated muscle adaptation	NFATC1 NFATC3 CAMTA2 CMYA5	4.61e-05	73	56	4	GO:0014888
GeneOntologyBiologicalProcess	vasculature development	RBM15 SP100 PIK3R6 NFATC1 NFATC3 ADAMTS9 EPHA2 LAMA1 MED1 NOTCH3 B4GALT1	4.96e-05	969	56	11	GO:0001944
GeneOntologyBiologicalProcess	type II interferon-mediated signaling pathway	SP100 NLRC5 MED1	5.29e-05	27	56	3	GO:0060333
GeneOntologyBiologicalProcess	blood vessel morphogenesis	RBM15 SP100 PIK3R6 NFATC3 ADAMTS9 EPHA2 LAMA1 MED1 NOTCH3 B4GALT1	6.13e-05	817	56	10	GO:0048514
GeneOntologyBiologicalProcess	morphogenesis of a branching structure	RBM15 NFATC1 NFATC3 EPHA2 LAMA1 MED1	6.95e-05	258	56	6	GO:0001763
GeneOntologyBiologicalProcess	negative regulation of DNA-templated transcription	ZNF512B ZBTB49 RBM15 SP100 HOXD9 NFATC1 NFATC3 PRAMEF14 ZNF589 MED1 PRAMEF1 PRAMEF2 NOTCH3	7.36e-05	1399	56	13	GO:0045892
GeneOntologyBiologicalProcess	negative regulation of RNA biosynthetic process	ZNF512B ZBTB49 RBM15 SP100 HOXD9 NFATC1 NFATC3 PRAMEF14 ZNF589 MED1 PRAMEF1 PRAMEF2 NOTCH3	8.15e-05	1413	56	13	GO:1902679
GeneOntologyBiologicalProcess	negative regulation of developmental process	ARHGAP4 RBM15 NFATC1 NFATC3 ADAMTS9 EPHA2 PRAMEF14 CDK5RAP2 MED1 PRAMEF1 PRAMEF2 NOTCH3	8.58e-05	1220	56	12	GO:0051093
GeneOntologyBiologicalProcess	circulatory system development	RBM15 SP100 PIK3R6 NFATC1 NFATC3 ADAMTS9 GLI1 EPHA2 LAMA1 MED1 RYR1 NOTCH3 B4GALT1	1.00e-04	1442	56	13	GO:0072359
GeneOntologyBiologicalProcess	positive regulation of response to type II interferon	NLRC5 MED1	1.08e-04	6	56	2	GO:0060332
GeneOntologyBiologicalProcess	positive regulation of type II interferon-mediated signaling pathway	NLRC5 MED1	1.08e-04	6	56	2	GO:0060335
GeneOntologyBiologicalProcess	negative regulation of cell differentiation	ARHGAP4 RBM15 NFATC1 NFATC3 PRAMEF14 CDK5RAP2 MED1 PRAMEF1 PRAMEF2 NOTCH3	1.08e-04	875	56	10	GO:0045596
GeneOntologyBiologicalProcess	angiogenesis	RBM15 SP100 PIK3R6 NFATC3 ADAMTS9 EPHA2 MED1 NOTCH3 B4GALT1	1.12e-04	708	56	9	GO:0001525
GeneOntologyBiologicalProcess	blood vessel development	RBM15 SP100 PIK3R6 NFATC3 ADAMTS9 EPHA2 LAMA1 MED1 NOTCH3 B4GALT1	1.77e-04	929	56	10	GO:0001568
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	ZBTB49 RBM15 SP100 CCPG1 HOXD9 NFATC1 NFATC3 GLI1 NLRC5 CAMTA2 MED1 NOTCH3	2.91e-04	1390	56	12	GO:0045944
GeneOntologyBiologicalProcess	tube development	RBM15 SP100 PIK3R6 NFATC1 NFATC3 ADAMTS9 GLI1 EPHA2 LAMA1 MED1 NOTCH3 B4GALT1	3.15e-04	1402	56	12	GO:0035295
GeneOntologyBiologicalProcess	calcineurin-NFAT signaling cascade	NFATC1 NFATC3 CMYA5	4.26e-04	54	56	3	GO:0033173
GeneOntologyBiologicalProcess	notochord morphogenesis	GLI1 EPHA2	4.70e-04	12	56	2	GO:0048570
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	ZNF512B ZBTB49 RBM15 SP100 HOXD9 NFATC1 NFATC3 ZNF589 MED1 NOTCH3	4.81e-04	1053	56	10	GO:0000122
GeneOntologyBiologicalProcess	calcineurin-mediated signaling	NFATC1 NFATC3 CMYA5	5.26e-04	58	56	3	GO:0097720
GeneOntologyBiologicalProcess	negative regulation of vascular associated smooth muscle cell differentiation	NFATC1 NFATC3	5.54e-04	13	56	2	GO:1905064
GeneOntologyBiologicalProcess	development of secondary sexual characteristics	MED1 B4GALT1	5.54e-04	13	56	2	GO:0045136
GeneOntologyBiologicalProcess	regulation of response to type II interferon	NLRC5 MED1	7.43e-04	15	56	2	GO:0060330
GeneOntologyBiologicalProcess	regulation of type II interferon-mediated signaling pathway	NLRC5 MED1	7.43e-04	15	56	2	GO:0060334
GeneOntologyBiologicalProcess	muscle tissue development	ANKRD33 HOXD9 NFATC3 ADAMTS9 GLI1 MED1 RYR1	7.51e-04	558	56	7	GO:0060537
MousePheno	abnormal soleus morphology	NFATC3 CMYA5 RYR1	3.33e-05	24	37	3	MP:0003081
MousePheno	abnormal tail morphology	HOXD9 ADAMTS9 EPHA2 PRAMEF14 PRAMEF1 PRAMEF2 PALB2	7.65e-05	403	37	7	MP:0002111
Domain	NFAT	NFATC1 NFATC3	8.16e-05	5	54	2	IPR008366
Domain	TIG	NFATC1 NFATC3 CAMTA2	9.70e-05	31	54	3	PF01833
Domain	IPT	NFATC1 NFATC3 CAMTA2	1.07e-04	32	54	3	IPR002909
Domain	RHD_dimer	NFATC1 NFATC3	3.64e-04	10	54	2	IPR032397
Domain	RHD_dimer	NFATC1 NFATC3	3.64e-04	10	54	2	PF16179
Domain	NFkB/Dor	NFATC1 NFATC3	3.64e-04	10	54	2	IPR000451
Domain	REL_1	NFATC1 NFATC3	3.64e-04	10	54	2	PS01204
Domain	RHD_DNA_bind_dom	NFATC1 NFATC3	3.64e-04	10	54	2	IPR011539
Domain	Phosphodiest	ENPP3 PIGO	3.64e-04	10	54	2	PF01663
Domain	RHD_DNA_bind	NFATC1 NFATC3	3.64e-04	10	54	2	PF00554
Domain	REL_2	NFATC1 NFATC3	3.64e-04	10	54	2	PS50254
Domain	-	NFATC1 NFATC3	3.64e-04	10	54	2	2.60.40.340
Domain	Phosphodiest/P_Trfase	ENPP3 PIGO	3.64e-04	10	54	2	IPR002591
Domain	Ig-like_fold	SNED1 NFATC1 NFATC3 IGHG3 EPHA2 ASTN1 CAMTA2 CMYA5	8.95e-04	706	54	8	IPR013783
Domain	EGF-like_CS	SNED1 EPHA2 LAMA1 ASTN1 NOTCH3	9.28e-04	261	54	5	IPR013032
Domain	EGF_2	SNED1 EPHA2 LAMA1 ASTN1 NOTCH3	9.93e-04	265	54	5	PS01186
Domain	PRAME_family	PRAMEF1 PRAMEF2	1.36e-03	19	54	2	IPR026271
Domain	FN3	SNED1 EPHA2 ASTN1 CMYA5	2.00e-03	185	54	4	SM00060
Domain	FN3	SNED1 EPHA2 ASTN1 CMYA5	2.61e-03	199	54	4	PS50853
Domain	IPT	NFATC1 NFATC3	2.75e-03	27	54	2	SM00429
Domain	hEGF	SNED1 NOTCH3	2.96e-03	28	54	2	PF12661
Domain	FN3_dom	SNED1 EPHA2 ASTN1 CMYA5	3.11e-03	209	54	4	IPR003961
Domain	Ig_E-set	NFATC1 NFATC3 CAMTA2	3.39e-03	104	54	3	IPR014756
Domain	Alkaline_phosphatase_core	ENPP3 PIGO	3.62e-03	31	54	2	IPR017850
Domain	Alkaline_Pase-like_a/b/a	ENPP3 PIGO	3.62e-03	31	54	2	IPR017849
Domain	-	ENPP3 PIGO	3.62e-03	31	54	2	3.40.720.10
Domain	Ank	ANKRD33 ANKRD34A CAMTA2 NOTCH3	4.24e-03	228	54	4	PF00023
Domain	EGF	SNED1 LAMA1 ASTN1 NOTCH3	4.72e-03	235	54	4	SM00181
Domain	-	ANKRD33 ANKRD34A CAMTA2 NOTCH3	5.71e-03	248	54	4	1.25.40.20
Domain	EGF-like_dom	SNED1 LAMA1 ASTN1 NOTCH3	5.79e-03	249	54	4	IPR000742
Domain	ANK_REPEAT	ANKRD33 ANKRD34A CAMTA2 NOTCH3	6.12e-03	253	54	4	PS50088
Domain	Ankyrin_rpt-contain_dom	ANKRD33 ANKRD34A CAMTA2 NOTCH3	6.20e-03	254	54	4	IPR020683
Domain	ANK_REP_REGION	ANKRD33 ANKRD34A CAMTA2 NOTCH3	6.20e-03	254	54	4	PS50297
Domain	EGF_1	SNED1 LAMA1 ASTN1 NOTCH3	6.29e-03	255	54	4	PS00022
Domain	Ankyrin_rpt	ANKRD33 ANKRD34A CAMTA2 NOTCH3	6.91e-03	262	54	4	IPR002110
Pathway	REACTOME_CALCINEURIN_ACTIVATES_NFAT	NFATC1 NFATC3	2.01e-04	9	34	2	M27106
Pathway	REACTOME_CALCINEURIN_ACTIVATES_NFAT	NFATC1 NFATC3	3.06e-04	11	34	2	MM14810
Pathway	REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION	NFATC1 NFATC3	3.06e-04	11	34	2	M27466
Pathway	KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY	NFATC1 NFATC3	3.67e-04	12	34	2	M47956
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY	NFATC1 NFATC3	6.63e-04	16	34	2	M47449
Pathway	KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION_IN_ICLR	SEM1 PALB2	6.63e-04	16	34	2	M47855
Pathway	KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN	NFATC1 NFATC3	7.51e-04	17	34	2	M47560
Pathway	BIOCARTA_CALCINEURIN_PATHWAY	NFATC1 NFATC3	8.43e-04	18	34	2	M3430
Pathway	KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY	NFATC1 NFATC3	8.43e-04	18	34	2	M47580
Pathway	REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI	NOTCH3 B4GALT1	8.43e-04	18	34	2	M614
Pathway	BIOCARTA_CALCINEURIN_PATHWAY	NFATC1 NFATC3	8.43e-04	18	34	2	MM1385
Pathway	KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY	NFATC1 NFATC3	9.41e-04	19	34	2	M47543
Pathway	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR	NFATC1 NFATC3 SEM1	9.62e-04	81	34	3	M595
Pubmed	Nuclear Factor of Activated T Cells-dependent Down-regulation of the Transcription Factor Glioma-associated Protein 1 (GLI1) Underlies the Growth Inhibitory Properties of Arachidonic Acid.	NFATC1 GLI1	2.64e-06	2	57	2	26601952
Pubmed	High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-κB ligand in osteoblasts.	NFATC1 NFATC3	2.64e-06	2	57	2	21514407
Pubmed	Senolytics prevent caveolar CaV 3.2-RyR axis malfunction in old vascular smooth muscle.	CACNA1H RYR1	2.64e-06	2	57	2	37837625
Pubmed	The promoter of the oocyte-specific gene, Oog1, functions in both male and female meiotic germ cells in transgenic mice.	PRAMEF14 PRAMEF1 PRAMEF2	3.35e-06	18	57	3	23894331
Pubmed	Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos.	PRAMEF14 PRAMEF1 PRAMEF2	3.35e-06	18	57	3	12890732
Pubmed	Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes.	PRAMEF14 PRAMEF1 PRAMEF2	3.35e-06	18	57	3	29731491
Pubmed	Identification of a new expanding family of genes characterized by atypical LRR domains. Localization of a cluster preferentially expressed in oocyte.	PRAMEF14 PRAMEF1 PRAMEF2	3.35e-06	18	57	3	14675769
Pubmed	Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways.	PRAMEF14 PRAMEF1 PRAMEF2	3.97e-06	19	57	3	28604677
Pubmed	Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins.	PRAMEF14 PRAMEF1 PRAMEF2	4.66e-06	20	57	3	26694250
Pubmed	Oog1, an oocyte-specific protein, interacts with Ras and Ras-signaling proteins during early embryogenesis.	PRAMEF14 PRAMEF1 PRAMEF2	4.66e-06	20	57	3	16580637
Pubmed	Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells.	PRAMEF14 PRAMEF1 PRAMEF2	4.66e-06	20	57	3	21425410
Pubmed	Sertoli cell-only phenotype and scRNA-seq define PRAMEF12 as a factor essential for spermatogenesis in mice.	PRAMEF14 PRAMEF1 PRAMEF2	6.29e-06	22	57	3	31729367
Pubmed	Oogenesis specific genes (Nobox, Oct4, Bmp15, Gdf9, Oogenesin1 and Oogenesin2) are differentially expressed during natural and gonadotropin-induced mouse follicular development.	PRAMEF14 PRAMEF1 PRAMEF2	7.22e-06	23	57	3	19480014
Pubmed	NFATc3, a lymphoid-specific NFATc family member that is calcium-regulated and exhibits distinct DNA binding specificity.	NFATC1 NFATC3	7.91e-06	3	57	2	7650004
Pubmed	ADAMTS9 activation by interleukin 1 beta via NFATc1 in OUMS-27 chondrosarcoma cells and in human chondrocytes.	NFATC1 ADAMTS9	7.91e-06	3	57	2	19052845
Pubmed	NFAT transcription factors are essential and redundant actors for leukemia initiating potential in T-cell acute lymphoblastic leukemia.	NFATC1 NFATC3	7.91e-06	3	57	2	34234374
Pubmed	Specific and redundant roles for NFAT transcription factors in the expression of mast cell-derived cytokines.	NFATC1 NFATC3	7.91e-06	3	57	2	17082579
Pubmed	Molecular cloning and functional characterization of murine cDNA encoding transcription factor NFATc.	NFATC1 NFATC3	7.91e-06	3	57	2	9388475
Pubmed	The transcription factor NFAT4 is involved in the generation and survival of T cells.	NFATC1 NFATC3	7.91e-06	3	57	2	9768749
Pubmed	MAGE-B4, a binding partner of PRAMEF12, is dispensable for spermatogenesis and male fertility in mice.	PRAMEF14 PRAMEF1 PRAMEF2	9.36e-06	25	57	3	37451217
Pubmed	Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei.	PRAMEF14 PRAMEF1 PRAMEF2	9.36e-06	25	57	3	12620990
Pubmed	Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3.	PRAMEF14 PRAMEF1 PRAMEF2	1.06e-05	26	57	3	18500982
Pubmed	Differences in gene expression between mouse and human for dynamically regulated genes in early embryo.	PRAMEF14 PRAMEF1 PRAMEF2	1.33e-05	28	57	3	25089626
Pubmed	Alternative splicing and expression of human and mouse NFAT genes.	NFATC1 NFATC3	1.58e-05	4	57	2	18675896
Pubmed	Transcription factors of the NFAT family: regulation and function.	NFATC1 NFATC3	1.58e-05	4	57	2	9143705
Pubmed	Sequential involvement of NFAT and Egr transcription factors in FasL regulation.	NFATC1 NFATC3	1.58e-05	4	57	2	10755616
Pubmed	Nuclear factor of activated T cells is activated in the endothelium of retinal microvessels in diabetic mice.	NFATC1 NFATC3	1.58e-05	4	57	2	25918731
Pubmed	A threshold level of NFATc1 activity facilitates thymocyte differentiation and opposes notch-driven leukaemia development.	NFATC1 NOTCH3	1.58e-05	4	57	2	27312418
Pubmed	NFAT isoforms play distinct roles in TNFα-induced retinal leukostasis.	NFATC1 NFATC3	1.58e-05	4	57	2	26527057
Pubmed	Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression.	MUC2 NOTCH3	1.58e-05	4	57	2	22691042
Pubmed	Normal B-1a cell development requires B cell-intrinsic NFATc1 activity.	NFATC1 NFATC3	1.58e-05	4	57	2	14595020
Pubmed	HIV-1 gp120 induces NFAT nuclear translocation in resting CD4+ T-cells.	NFATC1 NFATC3	1.58e-05	4	57	2	16260021
Pubmed	Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3+ regulatory T cells.	NFATC1 NFATC3	1.58e-05	4	57	2	22991461
Pubmed	The transcription factor nuclear factor of activated T cells c3 modulates the function of macrophages in sepsis.	NFATC1 NFATC3	1.58e-05	4	57	2	24970700
Pubmed	Calcineurin regulates innate antifungal immunity in neutrophils.	NFATC1 NFATC3	1.58e-05	4	57	2	20421389
Pubmed	Defective T cell development and function in calcineurin A beta -deficient mice.	NFATC1 NFATC3	1.58e-05	4	57	2	12091710
Pubmed	Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice.	PRAMEF14 PRAMEF1 PRAMEF2	1.64e-05	30	57	3	38786026
Pubmed	Functional analysis of secreted and transmembrane proteins critical to mouse development.	EPHA2 LAMA1 NOTCH3	1.82e-05	31	57	3	11431694
Pubmed	LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance.	PRAMEF14 PRAMEF1 PRAMEF2	2.00e-05	32	57	3	37889087
Pubmed	Down syndrome critical region-1 is a transcriptional target of nuclear factor of activated T cells-c1 within the endocardium during heart development.	NFATC1 NFATC3	2.63e-05	5	57	2	17693409
Pubmed	Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.	NFATC1 NFATC3	2.63e-05	5	57	2	22593154
Pubmed	Calcineurin B1 is essential for positive but not negative selection during thymocyte development.	NFATC1 NFATC3	2.63e-05	5	57	2	15030770
Pubmed	Selective role of NFATc3 in positive selection of thymocytes.	NFATC1 NFATC3	2.63e-05	5	57	2	17579027
Pubmed	NFAT: ubiquitous regulator of cell differentiation and adaptation.	NFATC1 NFATC3	2.63e-05	5	57	2	11877454
Pubmed	Human immunodeficiency virus type-1 tat enhances interleukin-2 promoter activity through synergism with phorbol ester and calcium-mediated activation of the NF-AT cis-regulatory motif.	NFATC1 NFATC3	2.63e-05	5	57	2	7999066
Pubmed	Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT.	NFATC1 NFATC3	2.63e-05	5	57	2	10089876
Pubmed	Retinoic acid receptors are required for skeletal growth, matrix homeostasis and growth plate function in postnatal mouse.	PRAMEF14 PRAMEF1 PRAMEF2	2.63e-05	35	57	3	19389355
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	CCPG1 ADAMTS9 PRAMEF14 CDK5RAP2 PRAMEF1 PRAMEF2	2.87e-05	363	57	6	14691545
Pubmed	Non-catalytic Roles for XPG with BRCA1 and BRCA2 in Homologous Recombination and Genome Stability.	SEM1 PALB2	3.94e-05	6	57	2	26833090
Pubmed	Calcineurin-dependent nuclear translocation of a murine transcription factor NFATx: molecular cloning and functional characterization.	NFATC1 NFATC3	3.94e-05	6	57	2	9017603
Pubmed	Increased dosage of DYRK1A and DSCR1 delays neuronal differentiation in neocortical progenitor cells.	NFATC1 NFATC3	3.94e-05	6	57	2	24352425
Pubmed	A strategy for probing the function of noncoding RNAs finds a repressor of NFAT.	NFATC1 NFATC3	3.94e-05	6	57	2	16141075
Pubmed	Cyclosporin A sensitivity of the HIV-1 long terminal repeat identifies distinct p56lck-dependent pathways activated by CD4 triggering.	NFATC1 NFATC3	3.94e-05	6	57	2	8814265
Pubmed	Regulation of T cell activation by HIV-1 accessory proteins: Vpr acts via distinct mechanisms to cooperate with Nef in NFAT-directed gene expression and to promote transactivation by CREB.	NFATC1 NFATC3	3.94e-05	6	57	2	12788643
Pubmed	The lncRNA NRON modulates HIV-1 replication in a NFAT-dependent manner and is differentially regulated by early and late viral proteins.	NFATC1 NFATC3	3.94e-05	6	57	2	25728138
Pubmed	A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis.	NFATC1 NFATC3	3.94e-05	6	57	2	15339668
Pubmed	Human immunodeficiency virus type 1 Tat increases cooperation between AP-1 and NFAT transcription factors in T cells.	NFATC1 NFATC3	3.94e-05	6	57	2	16690925
Pubmed	Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature.	NFATC1 NFATC3 EPHA2	4.58e-05	42	57	3	11439183
Pubmed	NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21.	NFATC1 NFATC3	5.51e-05	7	57	2	16554754
Pubmed	Extracellular HIV-Tat induces cyclooxygenase-2 in glial cells through activation of nuclear factor of activated T cells.	NFATC1 NFATC3	5.51e-05	7	57	2	18097055
Pubmed	Epithelial calcineurin controls microbiota-dependent intestinal tumor development.	NFATC1 NFATC3	5.51e-05	7	57	2	27043494
Pubmed	Scleraxis and NFATc regulate the expression of the pro-alpha1(I) collagen gene in tendon fibroblasts.	NFATC1 NFATC3	5.51e-05	7	57	2	17430895
Pubmed	Calcium/NFAT signalling promotes early nephrogenesis.	NFATC1 NFATC3	5.51e-05	7	57	2	21295565
Pubmed	Mbd3, a component of the NuRD co-repressor complex, is required for development of pluripotent cells.	PRAMEF14 PRAMEF1 PRAMEF2	6.03e-05	46	57	3	17287250
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	SIPA1L1 CDK5RAP2 EPB41L3 CARNS1	6.31e-05	130	57	4	12421765
Pubmed	Deterministic and stochastic allele specific gene expression in single mouse blastomeres.	HOXD9 GLI1 PRAMEF14 PRAMEF1 PRAMEF2 NOTCH3	6.80e-05	424	57	6	21731673
Pubmed	Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth.	NFATC1 NFATC3	7.34e-05	8	57	2	12370307
Pubmed	Interaction of HIV gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-kappa B and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity.	NFATC1 NFATC3	7.34e-05	8	57	2	7957556
Pubmed	NFATc1 regulates lymphatic endothelial development.	NFATC1 NFATC3	7.34e-05	8	57	2	19233265
Pubmed	MicroRNA-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells.	NFATC1 NFATC3	7.34e-05	8	57	2	23853098
Pubmed	Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor.	EPHA2 LAMA1	7.34e-05	8	57	2	8405064
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	PRAMEF14 PRAMEF1 PRAMEF2	7.74e-05	50	57	3	31806660
Pubmed	Embryonic attenuated Wnt/β-catenin signaling defines niche location and long-term stem cell fate in hair follicle.	NFATC1 GLI1	9.43e-05	9	57	2	26653852
Pubmed	Microbiota-dependent activation of the myeloid calcineurin-NFAT pathway inhibits B7H3- and B7H4-dependent anti-tumor immunity in colorectal cancer.	NFATC1 NFATC3	9.43e-05	9	57	2	35364006
Pubmed	Spatial and temporal regulation of coronary vessel formation by calcineurin-NFAT signaling.	NFATC1 NFATC3	1.18e-04	10	57	2	19710169
Pubmed	APRIN is a cell cycle specific BRCA2-interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancer.	SEM1 PALB2	1.44e-04	11	57	2	22293751
Pubmed	NRF2 Induction Supporting Breast Cancer Cell Survival Is Enabled by Oxidative Stress-Induced DPP3-KEAP1 Interaction.	LAMA1 PALB2	2.03e-04	13	57	2	28416489
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZNF512B ARHGAP4 CDK5RAP2 SYNPO WDR90 CARNS1	2.26e-04	529	57	6	14621295
Pubmed	Defining brain wiring patterns and mechanisms through gene trapping in mice.	LAMA1 NOTCH3	2.37e-04	14	57	2	11242070
Pubmed	Gli3 (Xt) and formin (ld) participate in the positioning of the polarising region and control of posterior limb-bud identity.	HOXD9 GLI1	2.37e-04	14	57	2	9834182
Pubmed	Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipients.	NFATC1 NFATC3	2.73e-04	15	57	2	21047202
Pubmed	Hoxd and Gli3 interactions modulate digit number in the amniote limb.	HOXD9 GLI1	2.73e-04	15	57	2	17714700
Pubmed	Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron.	LAMA1 SYNPO	3.12e-04	16	57	2	17229764
Pubmed	MARVELD1 depletion leads to dysfunction of motor and cognition via regulating glia-dependent neuronal migration during brain development.	GLI1 ASTN1	3.12e-04	16	57	2	30250269
Pubmed	ADAMTS18 Deficiency Affects Neuronal Morphogenesis and Reduces the Levels of Depression-like Behaviors in Mice.	ADAMTS9 LAMA1	3.12e-04	16	57	2	30579834
Pubmed	Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse.	PRAMEF1 PRAMEF2	3.53e-04	17	57	2	23565261
Pubmed	Mouse Pramel1 regulates spermatogonial development by inhibiting retinoic acid signaling during spermatogenesis.	PRAMEF1 PRAMEF2	3.53e-04	17	57	2	37781892
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	SIPA1L1 LAMA1 CDK5RAP2 RYR1	3.83e-04	208	57	4	33230847
Pubmed	Loss of endogenous thymosin β4 accelerates glomerular disease.	GLI1 SYNPO	3.97e-04	18	57	2	27575556
Pubmed	Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation.	PRAMEF1 PRAMEF2	3.97e-04	18	57	2	39181896
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	NFATC1 PLEKHM2 GLI1 ANKRD34A NLRC5 CACNA1H WDR90 RYR1	4.21e-04	1105	57	8	35748872
Pubmed	Plzf regulates limb and axial skeletal patterning.	HOXD9 GLI1	4.43e-04	19	57	2	10835630
Pubmed	Overexpression of TEAD-1 in transgenic mouse striated muscles produces a slower skeletal muscle contractile phenotype.	NFATC1 NFATC3	4.92e-04	20	57	2	18978355
Pubmed	Planar cell polarity effector gene Intu regulates cell fate-specific differentiation of keratinocytes through the primary cilia.	GLI1 NOTCH3	5.43e-04	21	57	2	22935613
Pubmed	Optic vesicle morphogenesis requires primary cilia.	GLI1 LAMA1	5.43e-04	21	57	2	32169553
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	ZNF512B SP100 ANKRD33 HOXD9 NFATC3 GLI1 MED1	5.59e-04	877	57	7	20211142
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	AMER2 SIPA1L1 SYNPO EPB41L3	5.68e-04	231	57	4	16452087
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	CCPG1 PLEKHM2 NYNRIN ANKRD34A	5.87e-04	233	57	4	37704626
Pubmed	CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP.	CNKSR1 ENPP3	5.97e-04	22	57	2	34187934
Pubmed	A new role for the calcineurin/NFAT pathway in neonatal myosin heavy chain expression via the NFATc2/MyoD complex during mouse myogenesis.	NFATC1 NFATC3	5.97e-04	22	57	2	24301466
Cytoband	1p36.21	PLEKHM2 PRAMEF14 PRAMEF1 PRAMEF2	1.20e-06	63	57	4	1p36.21
Cytoband	Ensembl 112 genes in cytogenetic band chr1p36	CNKSR1 PLEKHM2 EPHA2 PRAMEF14 PRAMEF1 PRAMEF2 VWA5B1	2.13e-05	681	57	7	chr1p36
GeneFamily	PRAME family	PRAMEF14 PRAMEF1 PRAMEF2	2.28e-05	24	42	3	686
GeneFamily	Nuclear factors of activated T-cells	NFATC1 NFATC3	5.24e-05	5	42	2	665
GeneFamily	Fibronectin type III domain containing	SNED1 EPHA2 ASTN1 CMYA5	5.09e-04	160	42	4	555
Coexpression	MORI_SMALL_PRE_BII_LYMPHOCYTE_UP	PRAMEF14 PRAMEF1 PRAMEF2 B4GALT1	6.23e-05	98	57	4	MM592
Coexpression	GSE27786_NKCELL_VS_NKTCELL_DN	ZNF512B HOXD9 NLRC5 CDK5RAP2 EPB41L3	7.29e-05	199	57	5	M4852
Coexpression	GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_DN	ARHGAP4 CCPG1 MFSD6 RYR1 B4GALT1	7.46e-05	200	57	5	M7744
Coexpression	GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	CCPG1 MTMR4 SEM1 SIPA1L1 B4GALT1	7.46e-05	200	57	5	M297
Coexpression	GSE27786_NKCELL_VS_ERYTHROBLAST_DN	SNED1 CNKSR1 EPHA2 EPB41L3 PALB2	7.46e-05	200	57	5	M4854
Coexpression	GSE31622_WT_VS_KLF3_KO_BCELL_UP	GLI1 ASTN1 CMYA5 RYR1 NOTCH3	7.46e-05	200	57	5	M8473
ToppCell	facs\|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF512B RBM15 SP100 MED1 B4GALT1	2.67e-06	171	57	5	c9990bc041a632b2f7bbebbfe737772c423d7027
ToppCell	10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	CCDC184 HOXD9 ADAMTS9 EPHA2 SYNPO	4.02e-06	186	57	5	e8ead5634686ebaa6a230eea69795d923ce9939d
ToppCell	COPD-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	ADAMTS9 CACNA1H SYNPO CARNS1 NOTCH3	4.24e-06	188	57	5	9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Mgp)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CNKSR1 HOXD9 C11orf91 NLRC5	6.76e-06	95	57	4	53dde5363ea1d64386234e5bd4fbb28c057f2f21
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Mgp)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CNKSR1 HOXD9 C11orf91 NLRC5	6.76e-06	95	57	4	ef0b7289b348617a76b4643479adc7e9701c0094
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Mgp)--\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CNKSR1 HOXD9 C11orf91 NLRC5	6.76e-06	95	57	4	8b4d6b25ce28811a76ea11713d881117e495ef5e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	AMER2 PIK3R6 ENPP3 RYR1	5.25e-05	160	57	4	fe9970c160159b35f6599ed13c89cfb49264d554
ToppCell	facs-Pancreas-Exocrine-18m-Hematologic\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP4 SP100 PIK3R6 NLRC5	5.38e-05	161	57	4	f5821f551cf5c64c9f75cdb723492c87aac1ece0
ToppCell	facs-Pancreas-Exocrine-18m-Hematologic-leukocyte\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP4 SP100 PIK3R6 NLRC5	5.38e-05	161	57	4	58a32a1033f379579697bda1bbf047a088e4a34f
ToppCell	facs-Pancreas-Exocrine-18m-Hematologic-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP4 SP100 PIK3R6 NLRC5	5.38e-05	161	57	4	16f77e7a5444d2f2b210362816cd7a07b9b42af6
ToppCell	PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SNED1 HOXD9 NFATC1 ENPP3	6.80e-05	171	57	4	686f95892c3909973c66c9a27159a070a068f175
ToppCell	PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SNED1 HOXD9 NFATC1 ENPP3	6.80e-05	171	57	4	f7ba03e7bdb687f93782c936c7b3374cc5b3b77c
ToppCell	facs\|World / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RBM15 SP100 MED1 B4GALT1	6.80e-05	171	57	4	5bcb96ed7fc15548f2dc9cf47482f890640cb39c
ToppCell	PND14-Endothelial-Endothelial_lymphatic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SNED1 HOXD9 NFATC1 ENPP3	6.80e-05	171	57	4	d0ac50071a3854d02113c455fcc940a6ec59bbb9
ToppCell	facs\|World / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RBM15 SP100 MED1 B4GALT1	6.80e-05	171	57	4	bb71e816dde44fda6af0ad98d979be9f8740fda6
ToppCell	PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SNED1 HOXD9 NFATC1 ENPP3	6.80e-05	171	57	4	fbf8e9db00573adcada4b25730e191417b7c9999
ToppCell	facs\|World / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RBM15 SP100 MED1 B4GALT1	6.96e-05	172	57	4	a2d0a64ebf09d219a07d6bbad1056bad6d46b9be
ToppCell	facs\|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RBM15 SP100 PROCA1 B4GALT1	7.44e-05	175	57	4	53e96956019f984decc1c81376ebc88fbf3c4d40
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GLI1 PROCA1 CDK5RAP2 NOTCH3	8.12e-05	179	57	4	b44e2d53b82c3c141bfc6539054b19708200a0d9
ToppCell	Children_(3_yrs)-Immune-B_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SP100 IGHG3 TMED8 NLRC5	8.29e-05	180	57	4	40a12eb852373ae3d7c8d9bca376b0ae99f724b3
ToppCell	COVID-19-Heart-Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADAMTS9 ASTN1 CACNA1H NOTCH3	8.47e-05	181	57	4	33cac65ed1ea5e7bd72250495df4f850b143d5aa
ToppCell	LV-07._Pericyte\|World / Chamber and Cluster_Paper	ADAMTS9 ASTN1 CACNA1H NOTCH3	8.84e-05	183	57	4	273db6a3b00a93ca852498471187b642b5368185
ToppCell	LA-07._Pericyte\|World / Chamber and Cluster_Paper	ADAMTS9 ASTN1 CACNA1H NOTCH3	8.84e-05	183	57	4	e3835db4795362b0442d5893baf2a78efcc20428
ToppCell	P03-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	HOXD9 NFATC1 ENPP3 ASTN1	8.84e-05	183	57	4	89727b4f65949ed2dce9d2e0228c79fe4280230c
ToppCell	P03-Endothelial-lymphatic_endothelial_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	HOXD9 NFATC1 ENPP3 ASTN1	8.84e-05	183	57	4	113e6d8d4bb271be984af06cd6c22b180425dcfc
ToppCell	LA-07._Pericyte\|LA / Chamber and Cluster_Paper	ADAMTS9 ASTN1 CACNA1H NOTCH3	9.22e-05	185	57	4	ba5baa4d7f097108622674de5b7f4fd279843d24
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GLI1 ENPP3 CACNA1H EPB41L3	9.22e-05	185	57	4	1b990e3089772be2b38c6d7ea0d1bf22461ae3ea
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1H WDR90 CARNS1 NOTCH3	9.22e-05	185	57	4	38486b69c48dc5e1c4e1488208fa8954a973eccb
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1H WDR90 CARNS1 NOTCH3	9.22e-05	185	57	4	3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658
ToppCell	COPD-Lymphoid-B\|World / Disease state, Lineage and Cell class	SNED1 SP100 IGHG3 SSH2	9.22e-05	185	57	4	22891ed75e25ef30dfa541cb82d85e08ce07e7d9
ToppCell	LV-07._Pericyte\|LV / Chamber and Cluster_Paper	ADAMTS9 ASTN1 CACNA1H NOTCH3	9.22e-05	185	57	4	acb38eba871ec72f2a8136a33b87d33b8c85465d
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-myeloid\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PIK3R6 ENPP3 CACNA1H EPB41L3	1.00e-04	189	57	4	2aebea7a6c2f83112d7c504b742f2c04b92e459a
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HOXD9 NFATC1 DBF4B LAMA1	1.00e-04	189	57	4	0739baad9a7da511dd3d7249f84299aee88370a1
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SNED1 HOXD9 ENPP3 SYNPO	1.02e-04	190	57	4	a1514d2186eb4fe569971ab22dc0c17d353fb94a
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLEKHM2 IGHG3 SIPA1L1 B4GALT1	1.02e-04	190	57	4	ed100e271aac82806f59e0c613ccda63f59100c1
ToppCell	BAL-Control-Lymphocyte-B-B_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SNED1 NFATC1 IGHG3 SIPA1L1	1.02e-04	190	57	4	da7341a8a423e5fe4d8e733d8e50c10a3318ac1c
ToppCell	BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SNED1 NFATC1 IGHG3 SIPA1L1	1.02e-04	190	57	4	682418a7a2096743112eae3790d40e7e600612c0
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SNED1 HOXD9 ENPP3 SYNPO	1.02e-04	190	57	4	0bb954a94317cfc742b9b6221bb80f8baa6d3ff1
ToppCell	BAL-Control-Lymphocyte-B-B_cell-B_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SNED1 NFATC1 IGHG3 SIPA1L1	1.02e-04	190	57	4	42312f7d79fe889397d32910b625793e2535cc26
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SNED1 HOXD9 ENPP3 SYNPO	1.02e-04	190	57	4	26e2237f65cb43723c5da853831b40df2982d6e4
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CNKSR1 ADAMTS9 NYNRIN CMYA5	1.06e-04	192	57	4	8899d81306770adda893b5e146df1253971754c5
ToppCell	human_hepatoblastoma-Endothelial_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	NFATC1 ADAMTS9 NLRC5 SYNPO	1.06e-04	192	57	4	e09f609fed033a25baacaf4a07bbbae1076da366
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CNKSR1 ADAMTS9 NYNRIN CMYA5	1.06e-04	192	57	4	5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAMTS9 ASTN1 CACNA1H NOTCH3	1.09e-04	193	57	4	7631bf3362b4fa061ffeab4879ab12c4708dc4c0
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAMTS9 ASTN1 CACNA1H NOTCH3	1.09e-04	193	57	4	8d15c63f2ae48d0a00d7ef5fdafa917ab8ad0571
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADAMTS9 ASTN1 WFDC8 CARNS1	1.11e-04	194	57	4	421344cc4b601d9745fa72d0af3124dab11d1d27
ToppCell	3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DBF4B EPHA2 NYNRIN B4GALT1	1.13e-04	195	57	4	6a0460d949ccda7c9fe76870d3ee6c2f60677d61
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SNED1 PIK3R6 NFATC1 IGHG3	1.15e-04	196	57	4	0175b097ad1338a07afebe3b5c7fd0bb0bb950f7
ToppCell	Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DBF4B SYNPO CARNS1 NOTCH3	1.17e-04	197	57	4	470e23dee4ca35e1fd021b7cdd58fcbc90639837
ToppCell	10x5'v1-week_12-13-Endothelial\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HOXD9 ADAMTS9 EPHA2 SYNPO	1.20e-04	198	57	4	307dd09e6bc820a148f3000f18dae7aedba4be0b
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CCDC184 ADAMTS9 CACNA1H NOTCH3	1.20e-04	198	57	4	f261a37dd07976548b897af86df1d1a0dc069889
ToppCell	MS-IIF-Lymphocyte-B-B_memory\|IIF / Disease, condition lineage and cell class	SP100 IGHG3 TMED8 SYNPO	1.20e-04	198	57	4	ae6f1d3ca7d7aa6f6f45b6b51aa8a967cadde017
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS9 CACNA1H CARNS1 NOTCH3	1.20e-04	198	57	4	7dd874b09c81cc512ccc1e9b65f290a5f94d736e
ToppCell	10x5'v1-week_12-13-Endothelial-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HOXD9 ADAMTS9 EPHA2 SYNPO	1.20e-04	198	57	4	122215d9288533ad03562cf777e846504863df9a
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	EPHA2 WDR90 CMYA5 B4GALT1	1.24e-04	200	57	4	0f4b8b0868bda406fe6bf01d1b722510fdfd0168
Drug	ICI 182,780; Down 200; 0.01uM; PC3; HT_HG-U133A	NFATC1 PLEKHM2 NFATC3 MFSD6 PIGO NOTCH3	9.07e-06	198	56	6	1238_DN
Drug	clozapine; Up 200; 10uM; MCF7; HT_HG-U133A_EA	SP100 CNKSR1 PLEKHM2 NFATC3 NYNRIN ZNF589	9.33e-06	199	56	6	1009_UP
Drug	Glimepiride [93479-97-1]; Down 200; 8.2uM; PC3; HT_HG-U133A	PLEKHM2 NFATC3 DBF4B ZNF589 SYNPO PIGO	9.60e-06	200	56	6	6628_DN
Drug	NSC92228	NFATC1 NFATC3	1.78e-05	3	56	2	CID000017897
Disease	pre-malignant neoplasm (biomarker_via_orthology)	GLI1 MUC2	4.56e-04	17	55	2	DOID:0060071 (biomarker_via_orthology)
Disease	inflammatory bowel disease (implicated_via_orthology)	EPB41L3 MUC2	9.96e-04	25	55	2	DOID:0050589 (implicated_via_orthology)
Disease	Drugs affecting bone structure and mineralization use measurement	NFATC1 SEM1	1.34e-03	29	55	2	EFO_0009936
Disease	free cholesterol in small HDL measurement	NYNRIN NLRC5	1.95e-03	35	55	2	EFO_0022270
Disease	Malignant neoplasm of breast	GLI1 SIPA1L1 ANKRD34A NLRC5 EPB41L3 PALB2 NOTCH3	3.67e-03	1074	55	7	C0006142

Protein segments in the cluster

Peptide	Gene	Start	Entry
HTTALSLPACPEESP	B4GALT1	121	P15291
HCDCAAETPAAEPPS	AMER2	46	Q8N7J2
LAHCIVDLPSSSDPP	LINC00269	41	Q8N2A0
PEAEAAHTPCSALEP	CAMTA2	401	O94983
APSLHAVPCCPLESE	CARNS1	521	A5YM72
CPLCHVTSSPDTPAE	ASTN1	951	O14525
LDTPGHLCPDSPESS	ANKRD34A	341	Q69YU3
SEICPPDDLASLPSC	CDK5RAP2	1051	Q96SN8
HCAPSPDRSPELSSS	RBM15	666	Q96T37
TTACHTLCPDHPPSL	ANKRD33	321	Q7Z3H0
TTPHKDCTPSPLCQL	MUC2	4681	Q02817
SSSCPPGLEHSLCPS	NFATC1	831	O95644
DCSLPDPCLSSPCAH	NOTCH3	116	Q9UM47
EPSACSDHPIPGCSL	HOXD9	241	P28356
EPRPCLDFDSPTHST	GLI1	876	P08151
SPAHPSVDPCTEESE	MFSD6	766	Q6ZSS7
SLCLSECPLEPPSLT	NLRC5	1111	Q86WI3
PPEHCPETEAVSALS	MTMR4	751	Q9NYA4
TPASDHCEPLLPTSS	PALB2	521	Q86YC2
DTQDCELPSCHPPPA	ADAMTS9	1156	Q9P2N4
TPTDSCEPAPECSSL	CCPG1	31	Q9ULG6
NPLPTESLDCFCPHL	ENPP3	566	O14638
TTPLHEEVSPCPCLR	DBF4B	526	Q8NFT6
SESPCLECPEHTLPS	EPHA2	286	P29317
ECDSPICLTSPSEHT	CMYA5	971	Q8N3K9
DTTHTCPRCPEPKSC	IGHG3	106	P01860
PSCEATPHRDSLEPT	CACNA1H	2221	O95180
PSRCLSHTDFVPCPV	RYR1	841	P21817
ATPSSHCERPESPCA	CCDC184	151	Q52MB2
TCSHVIESPCFELTP	PROCA1	121	Q8NCQ7
LGTDSCPLSPPSTHC	EPB41L3	506	Q9Y2J2
DTLDTPHITPAPSQC	MED1	731	Q15648
ISDSHSDPEVLICPP	NYNRIN	211	Q9P2P1
EDPTDESLGPTPCHC	PLEKHM2	751	Q8IWE5
TPCHCSPPEGTITKE	PLEKHM2	761	Q8IWE5
PCPSCGSSPSEELEL	PRAMEF14	456	Q5SWL7
ESSSHTPELARCPSP	SYNPO	741	Q8N3V7
TCDPETGECVCPPHT	LAMA1	1006	P25391
SHCPLPAAPVTDHTC	PIK3R6	631	Q5UE93
PPHDDCTPRRSCSET	SIPA1L1	1026	O43166
SPPPSLVHCEDCSCL	SEM1	96	Q6ZVN7
PCPSCGSSPSEELEL	PRAMEF1	456	O95521
PCPSCGSSPSEELEL	PRAMEF2	456	O60811
SELVHRPEPCTSPEA	ARHGAP4	831	P98171
NASHSLPSPCDSDPC	SNED1	536	Q8TER0
LPSDPEEHSHLCPLT	CNKSR1	696	Q969H4
CPSTPRLASASHPEE	C11orf91	126	Q3C1V1
PPSCHSDIDCPQTDK	WFDC8	166	Q8IUA0
VHPEPCPSLTLSEDA	WDR90	926	Q96KV7
DCLPEREPASCESPH	SSH2	1271	Q76I76
CPLPCDEESPEAELH	SP100	266	P23497
SLICHSLCDPASFPP	NFATC3	991	Q12968
PPCEVDSPSFPCTHC	ZNF512B	621	Q96KM6
CPEETPVCHSSPWLS	PIGO	641	Q8TEQ8
PCAVSHSECILESPE	ZBTB49	256	Q6ZSB9
ESKPEVHTCPSCPLA	ZNF589	76	Q86UQ0
LLASATDPEPCSSPH	TMED8	51	Q6PL24
LCTSSPPRHPSCDSF	VWA5B1	1106	Q5TIE3